Ranbaxy Laboratories Ltd (RANB.NS)

RANB.NS on National Stock Exchange of India

1 Apr 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for RANB.NS


Ranbaxy Laboratories Limited (Ranbaxy) is a research-based international pharmaceutical company serving customers in over 150 countries. The Company develops, manufactures and markets generic, branded generic, value-added and over-the-counter (OTC) products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and... (more)


Beta: 0.28
Market Cap(Mil.): Rs365,739.81
Shares Outstanding(Mil.): 425.66
Dividend: --
Yield (%): --


  RANB.NS Industry Sector
P/E (TTM): -- 33.50 33.65
EPS (TTM): -19.13 -- --
ROI: -- 14.69 14.17
ROE: -- 15.59 15.20

EU court to rule on drugmaker Lundbeck's pay-for-delay deals

BRUSSELS, Sept 6 Europe's top court will rule on Thursday whether Danish drugmaker Lundbeck breached EU antitrust rules by paying smaller rivals to delay generic copies of its blockbuster citalopram anti-depressant from entering the market.

06 Sep 2016

BRIEF-Daiichi Sankyo announces outcome of arbitration proceeding with Ranbaxy

* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former shareholders Ranbaxy Laboratories Ltd. on May 3

06 May 2016

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners

MUMBAI The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sankyo Co Ltd, they said on Thursday.

05 May 2016

Earnings vs. Estimates